Andrew Brackmann
Stock Analyst at William Blair
(4.85)
# 372
Out of 4,609 analysts
155
Total ratings
70.6%
Success rate
37.3%
Average return
Main Sectors:
Stocks Rated by Andrew Brackmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Rated: Hold | n/a | $170.66 | - | 4 | Jul 2, 2026 | |
| QDEL QuidelOrtho | Rated: Hold | n/a | $17.50 | - | 12 | Jul 2, 2026 | |
| XGN Exagen | Rated: Hold | n/a | $6.65 | - | 8 | Jul 2, 2026 | |
| BFLY Butterfly Network | Maintained: Buy | n/a | $8.42 | - | 10 | Jun 18, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | n/a | $24.60 | - | 12 | Jun 16, 2026 | |
| DGX Quest Diagnostics | Maintained: Buy | n/a | $235.84 | - | 6 | Jun 15, 2026 | |
| TEM Tempus AI | Reiterated: Hold | n/a | $46.70 | - | 11 | Jun 1, 2026 | |
| NEO NeoGenomics | Maintained: Hold | n/a | $15.73 | - | 11 | May 27, 2026 | |
| CDNA CareDx | Reiterated: Hold | n/a | $45.50 | - | 7 | May 27, 2026 | |
| GH Guardant Health | Maintained: Buy | n/a | $163.18 | - | 14 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.4336 | - | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $274.62 | - | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.50 | - | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.00 | - | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $149.97 | - | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $46.15 | - | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.78 | - | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $313.96 | - | 5 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $41.95 | -9.42% | 7 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $105.71 | - | 2 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.60 | n/a | 1 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $5.55 | n/a | 1 | Feb 3, 2022 |
Becton, Dickinson and Company
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $170.66
Upside: -
QuidelOrtho
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $17.50
Upside: -
Exagen
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $6.65
Upside: -
Butterfly Network
Jun 18, 2026
Maintained: Buy
Price Target: n/a
Current: $8.42
Upside: -
Adaptive Biotechnologies
Jun 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.60
Upside: -
Quest Diagnostics
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $235.84
Upside: -
Tempus AI
Jun 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $46.70
Upside: -
NeoGenomics
May 27, 2026
Maintained: Hold
Price Target: n/a
Current: $15.73
Upside: -
CareDx
May 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $45.50
Upside: -
Guardant Health
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $163.18
Upside: -
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4336
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $274.62
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.50
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $2.00
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $149.97
Upside: -
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $46.15
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $22.78
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $313.96
Upside: -
Apr 28, 2026
Maintained: Hold
Price Target: $38
Current: $41.95
Upside: -9.42%
Jan 23, 2026
Maintained: Buy
Price Target: n/a
Current: $105.71
Upside: -
Oct 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.60
Upside: n/a
Feb 3, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $5.55
Upside: n/a